Galicaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

RCT-2100 is under development for the treatment of cystic fibrosis (CF). The therapeutic candidate is an mRNA, encoding cystic fibrosis transmembrane conductance regulator (CFTR). It is administered ...

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

What's better than one dual meet? Two, of course. General McLane wrestling hosted the Corry boys and girls for a doubleheader Thursday on "Takedown Cystic Fibrosis" night.

READING HOSPITAL FOUNDATION Five Berks County professionals have been added to the Reading Hospital Foundation’s board of directors. Brian Boland, Esq., Dr. Anthony Donato, Kristi Gage-Linderman, P.

LCI proves valuable in monitoring ETI therapy effectiveness for cystic fibrosis patients with minimal FEV1 changes, detecting ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

A new charity football team in Peterborough has been set up to honour the memory of Jordan Smith and raise awareness of ...

Miss America pageant will take place in Orlando on January 5. This year's contestants include a national figure skater and a ...

Sophie Pierce is determined to make the most of her life - however long she may have.

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Stockard has completed the interview portion of the competition and is now preparing for on-stage competition, which, for her, begins Wednesday.